For example, tumor-derived APOE induced senescence of TRME and NEU cells, and that the removal of senescent cells neu by HDAC inhibitors could improve the therapeutic efficacy of prostate cancer treatment. The gene discussed is HDAC9; the disease is Familial prostate cancer.